A recent report by KD market insights titled as "Primary Biliary Cirrhosis Drugs Market Size, Trends &
Opportunity Outlook – Forecast to 2024" provides the key
trends, opportunities and challenges market will face in the forecasted period
of 6 years i.e. 2019-2024. The study also provides the Primary Biliary Cirrhosis Drugs Market. competitors share
and region wise analysis around the globe.
The market research report
demonstrates market dynamics which includes growth drivers, restraining factors
and opportunities and trends spearheading current Drug and future status of
this market. Our general approach is to target several individuals with
specific questions that we believed would satisfy our research objective.
Further, to speed up the data collection process, we employed an online survey,
delivered via email. The research team analyzed the results to identify
potential opportunities and risks for the market.
In addition, the report
offers recent industry activities and value chain analysis for the Primary
Biliary Cirrhosis Drugs Market. Moreover, Porter’s Five Forces analysis
demonstrates the five forces which include buyers bargaining power, suppliers
bargaining power, the threat of new entrants, the threat of substitutes, and
degree of competition in Primary Biliary Cirrhosis Drugs Market. Along with
figures and tables, a market attractiveness and BPS analysis has been provided
for every segment in the report.
Global Primary Biliary
Cirrhosis Drugs Market Size & Forecast:
Global Primary Biliary
Cirrhosis Drugs market witnessed a market value of USD XX Million in 2019 and
is estimated to reach USD XX million in 2024, registering a compound annual growth
rate (CAGR) of XX% between 2019 and 2024. The report analyses the market by
geographies i.e. North America, Europe, Asia Pacific, Latin America &
Middle East & Africa. Further, the geographies are fragmented into the
country and regional groupings:
- North America (U.S.
& Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)
Global Primary Biliary
Cirrhosis Drugs Market Segmentation:
The research offers a
comprehensive analysis of global Primary Biliary Cirrhosis Drugs market with
respect to following sub-markets:
Based on Drug:
- Ursodeoxycholic acid (USDA)
- - - Ursodiol
- Obeticholic acid
- - - Ocaliva
- Others (anti-inflamatory, anti-pruritics, and antihistamines)
- Ursodeoxycholic acid (USDA)
- - - Ursodiol
- Obeticholic acid
- - - Ocaliva
- Others (anti-inflamatory, anti-pruritics, and antihistamines)
Based on Distribution
Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Primary Biliary
Cirrhosis Drugs Market: Competitive Landscape
The report also highlights
the competitive landscape of the global Primary Biliary Cirrhosis Drugs market,
market share and positioning of all the major players in the industry. The
competitive landscape analysis provides detailed strategic analysis of the
company’s business and performance such as company overview, financial
information, revenue breakup by segment and by geography, SWOT Analysis, key
facts, business strategy, key product offerings, marketing and distribution
strategies, new product development, recent news (acquisition, expansion, Drug
development, research & development and other market activities).
The report includes
profiles of leading companies in the global Primary Biliary Cirrhosis Drugs
market.
Some of the key players
profiled include:
- Intercept
Pharmaceuticals, Inc.
- Johnson & Johnson
- GlaxoSmithKline Plc.
- Dr. Falk Pharma GmbH
- Enanta Pharmaceuticals, Inc.
- Other Major & Niche Key Players
- Johnson & Johnson
- GlaxoSmithKline Plc.
- Dr. Falk Pharma GmbH
- Enanta Pharmaceuticals, Inc.
- Other Major & Niche Key Players
Get Complete Research Report
with TOC @: https://www.kdmarketinsights.com/product/5547/primary-biliary-cirrhosis-drugs-market
Table Of Content:
1. Preface
1.1. Research Methodology
1.1.1. Industry Research
1.1.2. Research Process
and Design
1.1.2.1. Secondary
Research
1.1.2.2. Key Sources and
Use of Primary Research
1.1.2.3. Market Size
Estimation and Forecast
1.1.2.4. Research Report
1.2. Geographic Scope
1.3. Years Considered
1.4. Key Deliverables of
the Study
1.5. Assumptions and
Limitations for Market Estimation and Forecasting
2. Executive Summary
2.1. Market Snapshot
2.2. Market Overview
2.3. CXO Perspective
2.4. Top Global Primary
Biliary Cirrhosis Drugs Market Trends for 2019
3. Porter’s Five Force
Analysis
3.1. Threat of Substitutes
3.2. Bargaining Power of
Buyers
3.3. Bargaining Power of
Suppliers
3.4. Threat of New
Entrants
3.5. Degree of Competition
4. Manufacturing Cost
Structure Analysis
4.1. Raw Material and
Suppliers
4.2. Industry Chain
Structure of Primary Biliary Cirrhosis Drugs
4.3. Manufacturing Process
Analysis of Primary Biliary Cirrhosis Drugs
4.4. Manufacturing Cost
Structure Analysis of Primary Biliary Cirrhosis Drugs
5. Manufacturing Plants
Analysis of Primary Biliary Cirrhosis Drugs
5.1. Capacity and
Production
5.2. Global Primary
Biliary Cirrhosis Drugs Manufacturing Plants Distribution
5.3. Recent Development
and Expansion Plans
6. Competitive
Landscape
6.1. Global Primary
Biliary Cirrhosis Drugs Market 2018
6.2. Global Primary
Biliary Cirrhosis Drugs Market Value Share, By Company 2018
6.3. Global Primary
Biliary Cirrhosis Drugs Market Volume Share, By Company 2018
7. Market Dynamics
7.1. Growth Drivers &
Barriers in Primary Biliary Cirrhosis Drugs Market
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Rest of World
7.2. Opportunities in
Primary Biliary Cirrhosis Drugs Market
8. Global Primary
Biliary Cirrhosis Drugs Market
8.1. Introduction
8.2. Key Trends &
Growth Drivers
8.3. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
8.4. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9. Global Primary
Biliary Cirrhosis Drugs Market Segmentation Analysis, By Drug
9.1. Introduction
9.2. Strategic Insights
9.2.1. BPS Analysis, By
Drug
9.2.2. Market
Attractiveness, By Drug
9.3. Ursodeoxycholic acid
(Ursodiol)
9.3.1. Key Trends &
Growth Drivers
9.3.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4. Obeticholic acid
(Ocaliva)
9.4.1. Key Trends &
Growth Drivers
9.4.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5. Others
(anti-inflamatory, anti-pruritics, and Antihistamines)
9.5.1. Key Trends &
Growth Drivers
9.5.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10. Global Primary
Biliary Cirrhosis Drugs Market Segmentation Analysis, By Distribution Channel
10.1. Introduction
10.2. Strategic Insights
10.2.1. BPS Analysis, By
Distribution Channel
10.2.2. Market
Attractiveness, By Distribution Channel
10.3. Hospital Pharmacies
10.3.1. Key Trends &
Growth Drivers
10.3.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.3.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4. Retail Pharmacies
10.4.1. Key Trends &
Growth Drivers
10.4.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.5. Online Pharmacies
10.5.1. Key Trends &
Growth Drivers
10.5.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.5.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11. Geographical
Analysis
11.1. Introduction
11.2. North America
Primary Biliary Cirrhosis Drugs Market
11.2.1. Key Trends &
Growth Drivers
11.2.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4. By Drug
11.2.4.1. Introduction
11.2.4.2. Strategic
Insights
11.2.4.2.1. BPS Analysis,
By Drug
11.2.4.2.2. Market
Attractiveness, By Drug
11.2.4.3. Ursodeoxycholic
acid (Ursodiol)
11.2.4.3.1. Key Trends
& Growth Drivers
11.2.4.3.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.4.3.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.4.4. Obeticholic acid
(Ocaliva)
11.2.4.4.1. Key Trends
& Growth Drivers
11.2.4.4.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.4.4.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.5. Others
(anti-inflamatory, anti-pruritics, and Antihistamines)
11.2.4.5.1. Key Trends
& Growth Drivers
11.2.4.5.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.4.5.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.5. By Distribution
Channel
11.2.5.1. Introduction
11.2.5.2. Strategic
Insights
11.2.5.2.1. BPS Analysis,
By Distribution Channel
11.2.5.2.2. Market
Attractiveness, By Distribution Channel
11.2.5.3. Hospital
Pharmacies
11.2.5.3.1. Key Trends
& Growth Drivers
11.2.5.3.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.5.3.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.5.4. Retail
Pharmacies
11.2.5.4.1. Key Trends
& Growth Drivers
11.2.5.4.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.5.4.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.5.5. Online
Pharmacies
11.2.5.5.1. Key Trends
& Growth Drivers
11.2.5.5.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.5.5.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.6. By Country
11.2.6.1. Introduction
11.2.6.2. Strategic
Insights
11.2.6.2.1. BPS Analysis,
By Country
11.2.6.2.2. Market
Attractiveness, By Country
11.2.6.3. U.S. Primary
Biliary Cirrhosis Drugs Market
11.2.6.3.1. Key Trends
& Growth Drivers
11.2.6.3.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.6.3.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.6.4. Canada Primary
Biliary Cirrhosis Drugs Market
11.2.6.4.1. Key Trends
& Growth Drivers
11.2.6.4.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.2.6.4.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
11.3. Europe Primary
Biliary Cirrhosis Drugs Market
11.3.1. Key Trends &
Growth Drivers
11.3.2. Historical Market
Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.3. Historical Market
Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4. By Drug
11.3.4.1. Introduction
11.3.4.2. Strategic
Insights
11.3.4.2.1. BPS Analysis,
By Drug
11.3.4.2.2. Market Attractiveness,
By Drug
11.3.4.3. Ursodeoxycholic
acid (Ursodiol)
11.3.4.3.1. Key Trends
& Growth Drivers
11.3.4.3.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.3.4.3.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
11.3.4.4. Obeticholic acid
(Ocaliva)
11.3.4.4.1. Key Trends
& Growth Drivers
11.3.4.4.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.3.4.4.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
11.3.4.5. Others
(anti-inflamatory, anti-pruritics, and Antihistamines)
11.3.4.5.1. Key Trends
& Growth Drivers
11.3.4.5.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.3.4.5.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
11.3.5. By Distribution
Channel
11.3.5.1. Introduction
11.3.5.2. Strategic
Insights
11.3.5.2.1. BPS Analysis,
By Distribution Channel
11.3.5.2.2. Market
Attractiveness, By Distribution Channel
11.3.5.3. Hospital
Pharmacies
11.3.5.3.1. Key Trends
& Growth Drivers
11.3.5.3.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.3.5.3.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
11.3.5.4. Retail
Pharmacies
11.3.5.4.1. Key Trends
& Growth Drivers
11.3.5.4.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.3.5.4.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
11.3.5.5. Online
Pharmacies
11.3.5.5.1. Key Trends
& Growth Drivers
11.3.5.5.2. Historical
Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis,
2019-2024
11.3.5.5.3. Historical
Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis,
2019-2024
Continue:
About Us:
KD Market Insights offers a comprehensive database of syndicated
research studies, customized reports, and consulting services. These reports
are created to help in making smart, instant and crucial decisions based on
extensive and in-depth quantitative information, supported by extensive
analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement
of the client. We aim at providing value service to our clients. Our reports
are backed by extensive industry coverage and is made sure to give importance
to the specific needs of our clients. The main idea is to enable our clients to
make an informed decision, by keeping them and ourselves up to date with the
latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
Telephone: +1 (520) 300-1215
